With increasing number of immunocompromised patients as well as drug resistance in fungi,
the risk of fatal fungal infections in humans increases as well. The action of echinocandins is …

Abstract Purpose of Review Advances in health care over time have led to an evolution in
the epidemiology of invasive fungal infections. There is an increasing concern for antifungal …

As a consequence of the worsening situation with multidrug-resistant (MDR) pathogens and
a disparity in the commercialization of novel antimicrobial agents, scientists have been …

Candida auris is an emerging and frequently multidrug-resistant pathogen against which the
echinocandins are the preferred therapeutic option. We compared killing activities of …

ABSTRACT Introduction Invasive Candida Infections (ICIs) have undergone a series of
significant epidemiological, pathophysiological, and clinical changes during the last …

Candida auris is an emerging, multidrug-resistant fungal pathogen that causes refractory
colonization and life-threatening, invasive nosocomial infections. The high proportion of C …

Introduction Candida auris is responsible for hospital outbreaks worldwide. Some C. auris
isolates may show concomitant resistance to azoles, echinocandins, and polyenes, thereby …

Candida auris is emerging as a major global threat to human health. C. auris infections are
associated with high mortality due to intrinsic multi-drug resistance. Currently, therapeutic …

Candida auris is a recently emerged fungal pathogen that causes severe infections in
healthcare settings around the globe. A feature that distinguishes C. auris from other fungal …

Candida auris is a potential multidrug-resistant pathogen able to cause biofilm-associated
outbreaks, where frequently indwelling devices are the source of infections. The number of …